Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample

Journal of the American Geriatrics Society

Volumn 46, Issue 6, 1998, Pages 712-715

  Tilvis, Reijo S ^a   Strandberg, Timo E ^a   Juva, Kati ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGE; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; COGNITION; DEMENTIA; GENDER; HUMAN; MAJOR CLINICAL STUDY; MENTAL HEALTH; MORTALITY; PHENOTYPE;

EID: 0031744797     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb03805.x     Document Type: Article

References (20)

1. Van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-880.
2. Laakso M, Kesäniemi YA, Kervinen K et al. Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin-dependent diabetes mellitus. Br Med J 1991;303:1159-1162.
3. Kuusisto J, Koivisto K, Kervinen K et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: Population based study. Br Med J 1994;309:636-638.
4. Henderson AS, Easteal S, Jorm AF et al. Apolipoprotein E allele e4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-1390.
5. Saunders AM, Hulette C, Welsh-Bohmer KA et al. Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet 1996;348:90-93.
6. Relkin NR, Kwon YJ, Tsai J, Gandy S. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci 1996;802:149-176.
7. Post SG, Whitehouse PJ, Binstock RH et al. Consensus Statement. The clinical introduction of genetic testing for Alzheimer disease. An ethical perspective. JAMA 1997;277:832-836.
8. Lindroos M, Kupari M, Heikkilä J, Tilvis RS. Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225.
9. Pfeiffer RI, Kurosaki TT, Harrah CH et al. Measurement of the functional activities in older adults in the community. J Gerontol 1982;37:323-329.
10. Hughes C, Berg L, Danziger WL et al. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
11. Juva K, Sulkava R, Erkinjuntti T et al. The demented elderly in the city of Helsinki: Functional capacity and placement. J Am Geriatr Soc 1992;40:1146-1150.
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. Revised. DSM-III-R. Washington DC: American Psychiatric Association Press, 1987.
13. McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 1984;34:939-944.
14. Snowdon DA, Greiner LH, Mortimer JA et al. Brain infarction and the clinical expression of Alzheimer disease. JAMA 1997;277:813-817.
15. Rose GA. Chest pain questionnaire. Milbank Mem Fund Q 1965;43:32-39.
16. Ehnholm C, Lukka M, Kuusi T et al. Apolipoprotein E polymorphism in the Finnish population. Gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986;27:227-235.
17. Dixon WJ, Ed. BMDP. Statistical software. London: University of California Press, 1988.
18. Kukull WA, Schellenberg GD, Bowen JD et al. Apolipoprotein E in Alzheimer's disease risk and case detection: A case-control study. J Clin Epidemiol 1996;49:1143-1148.
19. Kontula K, Aalto-Setälä K, Kuusi T et al. Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction. Convenient alternative to phenotyping by isoelectric focusing. Clin Chem 1990;36:2087-2092.
20. Sobel E, Louhija J, Sulkava R et al. Lack of association of apolipoprotein E allele e4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-907.